Austco Healthcare HY Dec 24 Results Media Release
| Stock | Austco Healthcare Ltd (AHC.ASX) |
|---|---|
| Release Time | 27 Feb 2025, 8:08 a.m. |
| Price Sensitive | Yes |
Austco Healthcare reports strong HY results
- Revenue from customers up 62% to $36.9 million
- Software and SMA revenues up 15% to $4.6 million
- EBITDA increases 150% from $2.1 million to $5.2 million
Austco Healthcare Limited (ASX:AHC), a global leader in clinical communications solutions, has announced its results for the six months to 31 December 2024. The company reported record revenue from customers of $36.9 million, up 62% from the prior comparative period (pcp). This was underpinned by the successful integration of two recently acquired businesses, Teknocorp and Amentco, which contributed $11.9 million in revenue. The company also saw strong organic growth from Asia and North America. Software and SMA revenues increased by 15% to $4.6 million, highlighting the vital role they will play in driving the company's future growth and success. EBITDA increased by 150% from $2.1 million to $5.2 million, reflecting the strong operating leverage of the business model. Net Profit Before Tax (NPBT) was up 270% from $1.0 million in the pcp to $3.9 million. Austco's Unfilled Contracted Revenue (UCR) book remained steady at $50.2 million, with software and SMA revenues comprising 19.4% ($9.7 million) of the UCR. The company maintained its investment in research and development, outlaying $2.3 million, of which $0.9 million was capitalized. Austco remains debt-free, with cash of $14.9 million at 31 December 2024.
Austco Healthcare expects to deliver its record high order book of $50 million, while focusing on optimizing operational efficiencies, managing costs effectively, and maximizing revenue streams to drive profitability and long-term value creation for shareholders.
Austco Healthcare's key focus areas include innovation and product development, mergers and acquisitions, strategic partnerships and collaborations, and maintaining financial performance and sustainability. The company will continue to prioritize innovation, invest in developing solutions that address the evolving needs of healthcare organizations, and pursue strategic acquisitions and partnerships to strengthen its competitive edge and drive sustainable growth.